DPR Development has topped out its 12-story Eleven50 Eastlake life sciences mission in Seattle, the Redwood Metropolis, California-based builder advised Development Dive. The 450,000-square-foot facility consists of mission-critical lab and workplace house with retail on the bottom ground. DPR declined to share the price of the mission.
Development started in January 2021 and is ready to wrap this yr. Over the course of the 12-story mission, the builder bumped into challenges stemming from the pandemic, in response to DPR Development Undertaking Govt Michael Pearson.
“As with most initiatives began through the pandemic, our crew bumped into obstacles alongside the way in which starting from provide chain points to COVID-19-related shutdowns,” stated Pearson in an e-mail. “We’re proud that the crew remained resilient and met the challenges head on.”
San Francisco-headquartered structure agency Gensler designed the constructing, which additionally consists of areas to work, eateries and occasion areas. It’s going to goal LEED-Platinum and WELL-Platinum certification, per Gensler.
Remaining work consists of finishing the glass curtain wall façade; rooftop mechanical, electrical and plumbing; landscaping and hardscaping; inside core and amenity areas, in response to DPR. Its groups are at present progressing by the constructing inside to finish the tenant buildouts.
Signed tenants to Eleven50 embody pharmaceutical and biotech corporations Umoja Biopharma, Variant Bio, Notch, Altpep and Outpace Bio, in response to the Each day Journal of Commerce.